
Turning Point Therapeutics (TPTX) Latest News & Updates
Explore latest TPTX News and Updates
Stay updated on TPTX with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in TPTX
Order type
Buy in
Order amount
Est. shares
0 shares
GlobeNewsWire •



GlobeNewsWire •

GlobeNewsWire •


The Motley Fool •

Zacks Investment Research •

Zacks Investment Research •

Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients
GlobeNewsWire •

Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor
GlobeNewsWire •

Seeking Alpha •
